CD Biosynsis specializes in providing comprehensive strain engineering services tailored specifically for histidine production. Leveraging cutting-edge biotechnological techniques, we offer solutions that cater to the scientific community's specific needs.
The primary objective of strain engineering for histidine is to manipulate the genetic and metabolic pathways within the host organism to increase histidine production, improve its quality, or modulate its regulation. This process typically involves the selection and modification of key enzymes and regulatory elements involved in the histidine biosynthesis pathway.
Fig 1. Production of l-histidine from glucose by metabolically engineered Escherichia coli. (Wu H, et al., 2020)
By applying advanced biotechnological tools such as CRISPR-Cas9 genome editing and synthetic biology techniques, scientists can precisely alter the genetic makeup of microorganisms, plants, or cell cultures to achieve specific histidine-related goals. This technology has the potential to revolutionize histidine production, making it more efficient, cost-effective, and tailored to diverse research and industrial needs.
As a biotechnology company providing services for scientific purposes, our offerings encompass the following technological solutions:
Our strain engineering services provide a cutting-edge solution for your histidine needs in scientific research. With technical expertise, state-of-the-art techniques, and a commitment to quality, we are your trusted partner in the biosynthesis of histidine. Contact us today to discuss how we can support your research endeavors and elevate your scientific outcomes.
Production of l-histidine from glucose by metabolically engineered Escherichia coli.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.